CCCC vs MOS · rev $35.6M vs P/E 161, rev $11.12B
C4 Therapeutics Inc (CCCC) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
CCCC currently screens at market cap $425.7M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the CCCC and MOS stock pages for the full models.
Not investment advice.